This is eight fewer than the FDA, which approved 46 novel drugs in 2025 – sneaking in two regulatory decisions during the ...
Top of the list is that AIs must be human-centric by design and align with ethical values. They must be developed using a ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
"FDA and EMA release collaborative AI framework for drug development" was originally created and published by Pharmaceutical ...
The European regulator’s anniversary year featured first-in-class therapies, rare-disease advances, safety warnings, and new ...
EMA and FDA define ten principles for AI use in medicines – in response to growing pressure from the industry.